Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
Public ClinicalTrials.gov record NCT00301236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 5-Week Treatment, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of the Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules Administered Once Daily in Pediatric Children With Attention-Deficit/Hyperactivity Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
Study identification
- NCT ID
- NCT00301236
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2006 (Actual)
- Last update posted
- Dec 21, 2007
2006
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigational Site | Mesa | Arizona | 85210 | — |
| Novartis Investigational Site | Little Rock | Arkansas | 72205 | — |
| Novartis Investigational Site | Los Angeles | California | 90095 | — |
| Novartis Investigational Site | Boulder | Colorado | 80304 | — |
| Novartis Investigational Site | Maitland | Florida | 32751 | — |
| Novartis Investigational Site | Orlando | Florida | 32806 | — |
| Novartis Investigational Site | Stone Mountain | Georgia | 30083 | — |
| Novartis Investigational Site | Libertyville | Illinois | 60048 | — |
| Novartis Investigational Site | Overland Park | Kansas | 66211 | — |
| Novartis Investigational Site | Prairie Village | Kansas | 66206 | — |
| Novartis Investigational Site | Cambridge | Massachusetts | 02138 | — |
| Novartis Investigational Site | Las Vegas | Nevada | 89128 | — |
| Novartis Investigational Site | Piscataway | New Jersey | 08855 | — |
| Novartis Investigational Site | Toms River | New Jersey | 08755 | — |
| Novartis Investigational Site | New York | New York | 10029 | — |
| Novartis Investigational Site | New York | New York | 10032 | — |
| Novartis Investigational Site | Staten Island | New York | 10305 | — |
| Novartis Investigational Site | Chapel Hill | North Carolina | 27514 | — |
| Novartis Investigational Site | Raleigh | North Carolina | 27609 | — |
| Novartis Investigational Site | Columbus | Ohio | 43205 | — |
| Novartis Investigational Site | Gresham | Oregon | 97030 | — |
| Novartis Investigational Site | Philadelphia | Pennsylvania | 19149 | — |
| Novartis Investigational Site | Jackson | Tennessee | 38305 | — |
| Novartis Investigational Site | Memphis | Tennessee | 38119 | — |
| Novartis Investigational Site | Houston | Texas | 77007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00301236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2007 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00301236 live on ClinicalTrials.gov.